The Biden-Harris administration proposed a new rule on Tuesday that would expand coverage of the anti-obesity medications ...

If you’re taking a GLP-1 medication, some foods should be avoided — including a traditional favorite Getty There are a few ...

A class of drugs known as GLP-1s have been helping people lose weight, but out of pocket costs put them out of reach for many ...

MariTide, which like Eli Lilly’s Zepound is a dual agonist of the GLP-1 and GIP receptors, demonstrated an average weight ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were mostly higher early Tuesday after the Biden administration proposed a rule that would allow Medicare ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...

The proposal would slash out-of-pocket costs by as much as 95% for the drugs that can carry a price tag of $1,000 a month, ...

While this bodes well for weight loss, some users are concerned the drug's impact also means unwanted changes to their mood ...